Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Healer

MARCH 26, 2021

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. These include safer routes of administration, greater certainty of access, and better communication between patients and doctors.

Medicine 52

Medicine Legalization Chronic Pain Access 52

The Cannigma

JULY 6, 2022

There have been some studies around cannabinoids and certain terpenes effects on sleep, but most of this research is preclinical, which means it’s not tested on humans yet. A chemotype is a grouping of cannabis varieties based on their chemical composition, organized by its most dominant cannabinoid. THC and sleep.

Sleep 117

Sleep Terpenes Strains Chronic Pain 117

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Differentiate between fact and fiction by accessing trustworthy information. Implement research findings by consulting experts and translating data into practical actions.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Canna Care Docs

DECEMBER 16, 2020

Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain. What is medical marijuana?

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. The study, led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics , found anxiety was among the top three reasons for a medicinal cannabis prescription. The authors note, however, that the data doesn’t include patient outcomes. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Puff Puff Post

JANUARY 1, 2020

Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Veriheal

MAY 3, 2022

Kevin Potter taking responsibility for the integrity and accuracy of the data. The team sought to answer the following: “What are the risks and benefits of obtaining a medical marijuana card for adults who seek medical marijuana for pain, insomnia and anxiety or depressive symptoms?”—a Does the Data Justify the Conclusions?

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Puff Puff Post

JANUARY 1, 2020

Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Veriheal

JANUARY 4, 2021

In adults with chronic pain , what are the harms of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the harms of cannabinoids? In adults with chronic pain, what are the benefits of cannabinoids?

Chronic Pain 104

Chronic Pain Therapy Cannabinoids Treatment 104

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. Shedding Stigma and Promoting Patient Access. Patient access also hinges on a doctor’s preconceived notions of cannabis.

Education 66

Education Medicine Clinical Trials Patients 66

Veriheal

OCTOBER 5, 2020

These compounds mostly include cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) amongst many others such as cannabigerol (CBG). If you have experienced any of the benefits of having access to regulated and legalized edibles, let us know in the comment section below! . What are Cannabis Edibles?

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Veriheal

AUGUST 31, 2020

Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

MARCH 6, 2021

THC is the main psychoactive ingredient in cannabis, but it is not the only psychoactive cannabinoid. He added: “Some of the states with limited low-THC/high-CBD only access options also include caps, such as Georgia , but these are not traditional medical cannabis laws.”. The legal definition of hemp, which cannot go above 0.3%

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

DECEMBER 14, 2021

“Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available. We are proud to leverage our proprietary IP, formulation expertise, safety surveillance and patient reported data from the U.S.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Customers’ only way to know the levels of cannabinoids and other ingredients these products contain is by reviewing labels, marketing claims, and checking certificates of analysis.

THC 52

THC CBD Media Food 52

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

There are 400 chemical entities in the cannabis plant and more than 60 of them are cannabinoid compounds. Some of the research that has been done is purely observational, and it is difficult to draw any concrete conclusions or produce hard data. The journal of headache and pain , 19 (1), 1-28. There is just no way!

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

APRIL 8, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Yeah, there are thousands of strains, but those thousands of strains, but those thousands of strains only make let’s say one or two of 60 cannabinoids in abundance. This is by nature of the way we consume cannabinoids. Music by Desca.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Conclusions. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer.

Wellness and Beauty 145

Wellness and Beauty Data Terpenes Patients 145

The Cannigma

FEBRUARY 11, 2021

Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

MAY 13, 2019

In nearly every jurisdiction where medicinal cannabis is legal, at least one medical professional is required to sign off for a person to access it. The number of jurisdictions allowing access to medicinal cannabis has been steadily increasing since the state of California introduced legislation in 1996. Gardiner , Judith A.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer.

Wellness and Beauty 73

Wellness and Beauty Data Terpenes Strains 73

The Cannigma

JUNE 21, 2021

To address these limitations, the new work used data from 831 students (aged 12-21 years at baseline) gathered as part of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study. These data were analyzed in a model using age, sex, race, parental education, the previous year’s substance use as covariates. .

Sleep 61

Sleep Data Patients Chronic Pain 61

Canna Care Docs

AUGUST 21, 2019

That’s 47,600 lives lost in 2017 to opioid overdoses (or 70,237 if you included deaths from illegal opioids ), and the data from 2018 gives no indication that things are getting better. In that same year, over 130 people a day died from opioid-related drug overdoses. The OAPP has been a success so far,” Linn said in an email interview.

Chronic Pain 40

Chronic Pain Medicine Programs Patients 40

Sensi Seeds

DECEMBER 10, 2018

For the time being, and thanks to the onset of a new era of cannabis legalization, thousands of studies on cannabis and cannabinoids are published each year by the scientific community. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.

Medicine 81

Medicine Research and Development Data Policy 81

The Cannigma

JANUARY 19, 2022

She explains how the state legislature in New York prevented her from accessing the medication she needed, as well as how difficult it was navigating the world of medical cannabis and finding a product that reliably worked for her. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Music by Desca.

Patients 83

Patients Compliance Compliance Cannabis 83

StrainConnect

FEBRUARY 8, 2019

The difference between the cannabinoids CBD and THC. What are Cannabinoids? Cannabinoids(9) are the chemical compounds found within the Cannabis sativa L. As of August 2018, researchers have found more than “144 known cannabinoids” This, according to leading scientist, Dedi Meiri, Ph.D.(10)

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Cannabis Law Report

NOVEMBER 22, 2019

Medical cannabis users in Massachusetts are on track to regain access to vaping products starting Tuesday, November 12, after the Cannabis Control Commission did not uphold the Baker administration’s ban, though that permission could be short-lived amid ongoing legal challenges and potential future regulations from the commission.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

SEPTEMBER 19, 2019

CBD does not create the same high as THC and can be used for chronic pain and anxiety relief, according to Harvard Medical School. This leaves room for further growth, which may occur from the recent legalization of smokable flower and continued wide access to dispensaries.” in recent years.

Vaping 55

Vaping Hemp Education Patients 55